iShares Biotechnology ETF (NASDAQ:IBB) Shares Acquired by Sequoia Financial Advisors LLC

Sequoia Financial Advisors LLC raised its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 8.3% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,608 shares of the financial services provider’s stock after buying an additional 199 shares during the period. Sequoia Financial Advisors LLC’s holdings in iShares Biotechnology ETF were worth $380,000 at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Bbjs Financial Advisors LLC acquired a new stake in iShares Biotechnology ETF in the 2nd quarter valued at about $31,000. Chris Bulman Inc purchased a new position in shares of iShares Biotechnology ETF during the 2nd quarter worth approximately $64,000. BNP Paribas acquired a new position in shares of iShares Biotechnology ETF during the 1st quarter worth approximately $69,000. Financial Perspectives Inc lifted its stake in iShares Biotechnology ETF by 23.3% in the 1st quarter. Financial Perspectives Inc now owns 519 shares of the financial services provider’s stock valued at $71,000 after buying an additional 98 shares in the last quarter. Finally, Lynx Investment Advisory acquired a new stake in iShares Biotechnology ETF during the 2nd quarter valued at $74,000. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Price Performance

iShares Biotechnology ETF stock opened at $141.51 on Monday. iShares Biotechnology ETF has a fifty-two week low of $111.83 and a fifty-two week high of $150.57. The stock has a fifty day moving average of $145.56 and a two-hundred day moving average of $140.09.

iShares Biotechnology ETF Announces Dividend

The company also recently announced a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were paid a $0.2005 dividend. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.